A Multi-Modal Combination Intervention to Promote Cognitive Function in Older Intensive Care Unit Survivors

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age60+
SponsorUniversity of Washington

About this trial

Up to 25% of intensive care unit (ICU) survivors experience cognitive impairment comparable in severity to mild Alzheimer's disease and related dementias after hospital discharge. Older ICU survivors (ages 60 and older) are at highest risk for delirium and subsequent cognitive impairment, which contribute to higher risk for cognitive decline related to Alzheimer's disease and related dementias. Sleep and activity are essential for recovery from critical illness, yet ICU survivors experience both sleep deficiency and profound inactivity. About 75-80% of ICU patients experience circadian dysrhythmia, which contributes to cognitive decline and increases likelihood of developing Alzheimer's disease and related dementias. The scientific premises of the proposed study are: 1) a combined sleep promotion and cognitive training intervention will have synergistic effects to mitigate the risk of cognitive impairment and development of Alzheimer's disease and related dementias in older ICU survivors; and 2) chronotherapeutic timing of interventions (i.e., adjusting timing of interventions according to circadian rhythm) may improve intervention efficacy.

Eligibility criteria

Qualifiers

Age greater than or equal to 60 years old

Current hospitalization at University of Washington Medical Center or Harborview Medical Center

Intensive care unit (ICU) length of stay greater than 24 hours

Recovery from critical care status to acute care status, and/or discharge out of ICU

Disqualifiers

Documented history or suspicion of Alzheimer's disease or dementia, or current prescription of anti-dementia medication

Documented history of bipolar disorder or schizophrenia

Documented acute stroke or traumatic brain injury

Severe vision impairment

Trial design

Treatments tested in this trial

  • SLEEP + COG
  • COG
  • SLEEP
  • AC

Treatment groups

100 Participants
are divided into 4 treatment groups

Sponsors and collaborators

University of Washington

Lead sponsor

National Institute on Aging (NIA)

Collaborator